With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...
Hosted on MSN2d
From Goose Droppings to Medical Discovery: How a Chicago Student Found a Cancer-Fighting CompoundA middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...
Neumirna Therapeutics has raised €20m to develop microRNA therapies for epilepsy and other neurological conditions.
Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...
UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By ...
Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...
Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...
Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a ...
This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback